Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes, “pay”tience is what it takes.
The first of my non-Roth shares became long term capital gains eligible last month and with each week that passes more of them cross that threshold from short to long term. Paytience is what it takes to watch a business build itself from the ground up, and if people are looking for a quick buck I understand the frustration. That money should be taken elsewhere to try and make a quick buck. People waiting on Q2 2020, me too, but I’m looking forward to Q4 2021, and Q3 2022. I’m looking forward to watching my Roth shares grow over the next decade to something that will make for a great dinner time story years from now as I relate how the deck we are sitting on watching the sunset over the mountains was paid for by this sub-penny stock that became a monster player in the HAI field before taking off in other sectors too.
If it were red every day, wouldn’t we be sub-penny by now? I mean, that’s just flat out wrong information.
It hasn’t closed below .034 since April 8th (that is 100 trading days) and its traded between .036 and .052 since June 1st. Flippers paradise for those that can track it and flip it, but red every day is not reflected in the facts.
Yea, my three year old regularly produces 20-30 page documents covering activities in seventeen states.
Have you looked at the last few financial reports? Consistent growing revenues, increasing hospital placements and increasing distributors. Does the company have some unfavorable loans that were necessary for survival? Ummm, yea, welcome to business. Are they on the path to succeed through that and move to the next level? Absolutely.
MaxxxxxxxRevenues
What a jackass.
If it doesn’t clear a million it’s going to be close. I don’t know much about invoicing and when a business actually “counts” the receivables, but in looking at Q1 and with a four million dollar estimate for 2020 overall (regardless of whether people view that as conservative or optimistic) Q2 and Q3 will both be close to or over a million. Even if Gary is off by 25% and it’s only three million (which would be a large miss percentage-wise, most companies don’t miss estimates by that much barring catastrophic circumstances and in this case the catastrophe affecting the world is in our favor) we should still see around a million in Q2.
I envisioned it like the Death Star, except obviously a cross and not a star, fully equipped with laser beams and space missiles as it tromps around the OTC galaxy seeking to annihilate poor penny stock companies.
MaxxxxxGrrreeeennnnnn
MaxxxxxxxWhine
Five additional rack-mounted installations in an already existing customer hospital? That’s so far from lame it’s ridiculous. It validates confidence in the product, as the hospital is more than doubling down on their current investment in the Annihilyzer, plus another distributor? PCTL has a distribution footprint in seventeen states?!? That is huge exposure, and those distributors will be putting the product in front of more and more existing and potential customers.
Just because it’s not the Q2 numbers doesn’t mean the news ain’t great.
I mean, I’ve been here since July ‘19 and have 565K shares, so I would say I’ve figured it out.
Not based on merit, no, unless they come out of the woodwork with some craziness none of us except the extreme outliers expect. The OTC is wild though and there are ridiculous runs (often unsustained) for all kinds of unpredictable and inane reasons. I don’t see .40-.50 on merit until 2023 or later, If they continue to grow at the same pace or slightly better than they have.
I will say there are some potentially huge catalysts though. Obviously the U.K. and what that could be like, but accelerated hospital penetration here in the states could be huge, as could a dramatic expansion of the authorized distributor network. I mean, there is a lot of passive income potential within that network where money will just be coming in without much, if any, focus from the Company, allowing them to use That money to expand other revenue building streams. I remain incredibly optimistic about the middle and long term future, near term we remain at the mercy of a lot of variables.
Depending on if PRs are dropped in association with Q2, and the substance of those, I think it could spike to around .10 or .12 before settling back to .07-.08 to await Q3. There is a lot of hype around these two quarters and if the company can leverage that with additional news it could be powerful.
It’s Saturday.
Congratulations, that’s awesome to hear.
Serious question here... what does it matter if they’re delinquent right now? OTCMarkets has them as pink with no stop sign, so there is no restriction from certain companies on buying shares (I think?), so what negative things exist if They are currently delinquent with the SEC?
It’s like a laugh track for the GMGI show.
So... speculation?
That is completely speculative too though. There are platforms you can trade on with a stop sign up, I opened an E*TRADE account specifically to buy PCTL when the stop sign was up and as others have noted on this board, the biggest runs here have occurred with the stop sign up. Is there any actual data or evidence that a stop sign coming down results in a flood of new buyers?
Ah, so no real reasons.
I agree completely, today’s filing was necessary for us to be compliant with the filing process. It just amazes me that some people think there was a big event today that should have generated serious PPS growth, which there wasn’t. I hope the Q2, and more importantly Q3, drive that growth.
Any reasons you want to put forth to support this position?
When you whine about everything your credibility is kaput.
What happened today that should have moved it but was disappointing in its results?
That’s not expecting too much... I also expect the filings to be filed when they are due, but we know historically that hasn’t happened. Right now we are current, which is awesome. If we can stay current and they get these Q2 filings done within the allowed extension period, to me that is the first step in establishing a new pattern. If they get Q3 filed on time, it will be an indicator to me they have their act together more than they have historically and I’ll be optimistic moving forward. I’m just happy that after so many months of following this company and there being communication dead zones that they are working within the allowable system to ask for extensions and hopefully meet those timelines. We will see what happens this week!
I find it an appropriate use of the resources available to stay current rather than a reason to gripe. If they’re late on the Q2 after filing this, then let’s gripe.
Current again you mean?
MaxxxxGrreeeeeennnnn
It means they’re staying current, that’s a great thing.
Evidence? Moron.
No apologies needed! Have a great weekend :)
Second quarter 2019 over 2018 was that percentage, I believe, not the whole year.
MaxxFiliiinngggssss
Lol all the time asking for documents then unhappy with them.
You’re so wrong.
I wasn’t sure if it was a sarcastic poke at Q1 and Q2 2020 being late.
If the company has been growing more recently, I’m not sure how much it matters if it wasn’t growing further in the past. Big companies were small before, companies with high growth previously had low growth, and big companies could reduce growth or even shrink. I mean, that’s pretty much universal. It’s about projecting trajectory Based on what you know, and combining the growth pattern trending upward with what we know about the pandemic and other variables does anyone genuinely believe the company is NOT growing? I’m not speculating at what pace, or putting numbers out, but i would love to hear reasons on why Q1 and Q2 2020 may show a shrinking of revenues over 2019.
Do you mean Q1 and Q2 2019 over 2018?
https://www.otcmarkets.com/filing/html?id=14303420&guid=KMz6Upytg4yx8th
You mean this audited 10K, which shows 166% annual growth 2019 over 2018?
https://www.otcmarkets.com/filing/html?id=14071046&guid=mbz6U61eNbbYt
What about this 10Q, showing 435% year over year quarterly growth 2019 over 2018?
MaxxGrrrreeeeeeennnnnnn